Abstract-The copper transporter ATP7A has attracted significant attention since the discovery of its gene mutation leading to human Menkes disease. We previously reported that ATP7A is highly expressed in the human vasculature and identified a novel vascular function of ATP7A in modulation of the expression and activity of extracellular superoxide dismutase. We recently identified that ATP7A expression in THP-1 cells (a monocyte/macrophage model cell line) plays a role in the oxidation of low density lipoproteins, indicating that it is necessary to further investigate its expression and function in monocytes/macrophages. In the current study, we demonstrated the protein and mRNA expression of ATP7A in human peripheral blood mononuclear cell (PBMC)-derived macrophages and alveolar macrophages. ATP7A was strongly colocalized with the trans-Golgi apparatus in PBMC-derived macrophages. Intracellular copper, detected by synchrotron X-ray fluorescence microscopy, was found to be distributed to the nucleus and cytoplasm in human THP-1 cells. To confirm the role of endogenous ATP7A in macrophage copper homeostasis, we performed inductively coupled plasma mass spectrometry in murine peritoneal macrophages, which showed markedly increased intracellular copper levels in macrophages isolated from ATP7A-deficient mice versus control mice. Moreover, the role of ATP7A in regulating macrophage responses to dermal wounds was studied by introduction of control and ATP7A-downregulated THP-1 cells into dermal wounds of nude mice. Infiltration of THP-1 cells into the wounded area (detected by expression of human macrophage markers MAC2 and CD68) was reduced in response to downregulation of ATP7A, hinting decreased macrophage accumulation subsequent to dermal wounds. In summary, alongside our previous studies, these findings indicate that human macrophage ATP7A is localized in the trans-Golgi apparatus, regulates intracellular copper levels, and mediates macrophage responses to a dermal wound.
INTRODUCTION
Vascular metallomics is an emerging field for studying the biological role of metal cations and their signaling pathways in the vasculature [1] . Among the metal cations involved in vascular homeostasis, copper is an essential redox-active metal that is required for normal cellular function [2] . During the past decade, the copper trafficking theory has been established and validated in several laboratories [3] . This theory describes a group of copper chaperones and transporters that tightly regulate copper homeostasis in cells. Among these copper chaperones and transporters, ATP7A has attracted significant attention since the discovery that its gene mutation leads to Menkes disease [4] [5] [6] . We previously reported that ATP7A is highly expressed in the human vasculature, including aortic smooth muscle cells, aortic endothelial cells, and umbilical vein endo-ABBREVIATIONS: calcein AM, Calcein acetoxymethyl ester; cPLA 2α , Cytosolic phospholipase A 2α ; DAPI, 4′,6-Diamidino-2-phenylindole; DIC, Differential interference contrast; ICP-MS, Inductively coupled plasma mass spectrometry; PBMC, Peripheral blood mononuclear cell; PBS, Phosphate-buffered saline; PDGF, Platelet-derived growth factor; PMA, Phorbol-12-myristate-13-acetate; SXRF, Synchrotron X-ray fluorescence; VEGF, Vascular endothelial growth factor; VSMC, Vascular smooth muscle cell thelial cells [7] . Moreover, we identified a novel vascular function of ATP7A: modulation of the expression and activity of a copper-accepting enzyme, extracellular superoxide dismutase [7, 8] . Thus, it is compelling to investigate the expression and function of ATP7A in other vascular cell types, including macrophages.
Macrophages are a major component of innate immune defenses and are essential for tissue repair, angiogenic and inflammatory responses in vasculature. Earlier studies showed that dietary copper deficiency can influence macrophage function. For example, respiratory burst and microbicidal activities in vitro were reduced in peritoneal macrophages isolated from rats fed copper-deficient diets [9] ; reduced macrophage microbicidal activities are postulated to contribute to increased mortality in response to the bacterial challenges in copper-deficient rodents [10] . Very recently, White et al. discovered a molecular mechanism to interpret this phenomenon, showing that microbicidal activity in macrophages is attenuated after inhibition of ATP7A expression in RAW264.7 cells, a murine macrophage cell line [11] ; moreover, hypoxia stimulates ATP7A translocation in RAW 264.7 cells and tumor-associated macrophages in SCID mice [12] . Zheng et al. observed ATP7A expression in a murine cell line of microglia which is the resident macrophages of the brain [13] , and IFN-γ induces ATP7A expression in microglia [13] . These studies identified a previously underappreciated role of ATP7A in regulating macrophage function. We also reported that ATP7A expression was increased in THP-1 cells, a human monocyte/macrophage cell line, after exposure to phorbol-12-myristate-13-acetate (PMA) [14] , and that downregulation of ATP7A expression in THP-1 cells inhibited oxidation of low density lipoproteins [15] . Therefore, in the current study, we further characterized the expression, subcellular location, and copper regulatory function of ATP7A in freshly isolated primary macrophages. Moreover, we investigated the role of macrophage ATP7A in modulating responses to dermal wounds.
MATERIALS AND METHODS
Cells. The human THP-1 cells were obtained from the American Type Culture Collection (Rockville, MD) and maintained in culture using RPMI 1640 medium (Hyclone, Logan, UT) in the presence of 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 μg/ml). Cultures were maintained in 5% CO 2 tissue culture incubator maintained at 37°C until ready for use. Human alveolar macrophages were prepared from bronchoalveolar lavage fluids obtained from nonsmoking volunteers (kindly provided by Dr. Dennis McGraw at the University of Cincinnati with an approved IRB protocol). Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of health volunteers (Hoxworth Blood Center, University of Cincinnati Medical Center) by a Ficoll-Hypaque method. Macrophages were then generated by an adherence-based method in RPMI 1640 medium with 10% heat-inactivated human serum for 6-8 days before use. To prepare peritoneal macrophages, cells were harvested from the peritoneal cavity of mice 3 days after intraperitoneal administration of 3% thioglycollate broth (Sigma-Aldrich, St. Louis, MO). Cells were then plated onto tissue culture plastic overnight, and adherent cells were collected for further study.
Animals. The heterozygous blotchy ATP7A-deficient mouse females and wild-type males were obtained from the Jackson Laboratory (Bar Harbor, ME) to establish colonies. In the current study, male hemizygous mice carrying the X-linked blotchy ATP7A mutation and control littermates were used and designated as ATP7A-deficient mice (ATP7A −/y ) and control mice (ATP7A +/y ), respectively. Nude mouse males (Nu/J, 8-10 weeks) were also purchased from the Jackson Laboratory for the dermal wound study. All animal protocols were approved by the University of Cincinnati Institutional Animal Care and Use Committee.
Synchrotron X-ray Fluorescence Microscopy (SXRF). THP-1 cells were cultured under the same conditions as described above, except that an autoclave-sterilized silicon nitride window (500-nm thickness, 200-μm thick silicon frame, Silson Ltd., Northampton, UK) was added to each well prior to cell seeding. THP-1 cells were first incubated with 100 nM PMA to differentiate to the macrophage phenotype. Adherent cells were treated with 200 μM CuSO 4 for 4 h, washed in phosphate-buffered saline (PBS), and fixed by 4% paraformaldehyde in PBS for 10 min followed by air drying. This method of cell fixation and preparation for SXRF is comparable to plunge freezing method with the minimized disruption of metal topography and the limited alteration of typical cellular copper content [16] . SXRF was performed at beamline 2-ID-D of the Advanced Photon Source at the Argonne National Laboratory (Argonne, IL). Incident X-rays of 10 keV energy were chosen to excite elements Cu and Zn, accompanied by monochromatization with a monochromator. A Fresnel zone plate focused the X-ray beam to a spot size of 0.3×0.2 μm 2 on the specimen, which was raster-scanned in steps of 0.5 μm. Fluorescence spectrum from the specimen was captured for 1 s of dwell time. Spectral analysis of the fluorescence spectrum of each raster pixel then provided spatial images for Cu and Zn.
Western Blotting. Cell preparation and Western blotting to detect ATP7A protein levels was performed as described previously [7] .
RT-PCR. Total RNA preparation and RT-PCR were performed as described previously [15] . The sequences of RT-PCR primers for the target genes were produced using Primer 3 (http://frodo.wi.mit.edu/primer3/).
Immunofluorescence and Confocal Microscopy. Cells were plated at 1×10 5 per 35 mm dish onto coverslips for 24 h. Cells were washed in 100 mM of PBS, pH 7.4, and fixed in 4% paraformaldehyde, pH 7.4 (20 min, 4°C). After washing with PBS again, proteins were localized using the primary antibodies: ATP7A (1:100) or TGN46 (1:100) (overnight, 4°C). Cells were then washed and incubated with secondary antibodies coupled to rhodamine red-X or FITC (1:200, 1 h, room temperature), respectively. The stained cells were mounted on slides in Vectashield antifade medium (Vector Laboratories, Burlingame, CA). Cells were observed with a Zeiss Axioplan Imaging 2 microscope coupled to a cooled, charge-coupled device camera. Images were captured with Metamorph software and merged with Photoshop software. Cells were also observed with a Zeiss laser-scanning confocal microscope (LSM Meta 510) using argon laser excitation parameters of 488 and 514 nm with emission filters of 540/30 and 580/ 32 nm. Images were captured with Zeiss software and merged with Photoshop software.
Inductively Coupled Plasma Mass Spectrometry. Cell sample preparation was performed as described in our previous publication [14] . For tissue sample preparation, after harvesting, the tissue was placed in a Petri dish and cut into fine pieces before being stored at −80°C for future assay. After transferring to a liquid nitrogencooled mortar, the tissue was ground into powder with a pestle. Then the tissue was transferred to a 1 mL glass tissue grinder for a second homogenization. The homogenized tissue was then digested in nitric acid (final concentration 5%). An Agilent 7500ce system (Agilent Technologies, Santa Clara, CA) was used to detect the copper concentration in cells and tissues. Instrumental parameters were as follows: forward power, 1,500 W; plasma gas flow rate, 15.0 L min −1 ; auxiliary gas flow rate, 1.0 L min −1 ; carrier gas flow rate, 0.99 L min −1 ; makeup gas flow rate, 0.14 L min −1 ; and monitored isotope, 63 Cu. Samples were read five times for cell samples and three times for tissue samples and then averaged for reproducibility. The sample values were normalized to total protein content, as determined by a bicinchoninic acid protein assay.
Dermal Wound Experiment. Using a sterile 3-mm biopsy punch, full-thickness skin wounds were created on the dorsorostral back skin without injuring the underlying muscle. THP-1 cells (1×10 6 ) were grown on polyethylene-coated silica microcarrier beads and incubated with either 5 nM of ATP7A-specific or control siRNA oligonucleotides for 24 h. The efficacy of ATP7A siRNA in THP-1 cells is demonstrated in our previous studies [14, 15] . The beads were then loaded into the skin on day 4 after wounding. Following 7 h of incubation, the microcarrier beads were removed and the wound was carefully washed with PBS before a collection for further assays. Wound tissue biopsies containing THP-1 cells labeled with or without a fluorescence marker, calcein acetoxymethyl ester (calcein AM, 1.5 μM; Anaspec) were imaged with a Zeiss LSM510 META confocal microscope (argon laser excitation wavelength of 488 nm with emission filters of 505/550 nm).
Statistical Analyses. Data are presented as mean ± SEM. Data were compared between groups by Student's t test when one comparison was performed or by ANOVA for multiple comparisons. When significance was indicated by ANOVA, the TukeyKramer post hoc test was used to specify betweengroup differences. Values of p<0.05 were considered statistically significant.
RESULTS

Subcellular Copper Topography in Human Macrophages.
Using SXRF, we detected intracellular copper in THP-1 cells after incubation with copper ( Fig. 1 ). Because as a co-factor of transcription factor, zinc mainly accumulates in the nucleus, we compared the topography of copper (Fig. 1a) and zinc (Fig. 1b) . This study showed that although both metals co-localized within the nucleus, a significant amount of copper was also detected in the cytoplasm in THP-1 cells, presumably is localized in mitochondrion and trans-Golgi apparatus of cytoplasm [17] .
Human Macrophage Expressing ATP7A. Previously, we reported that ATP7A is expressed in the human THP-1 cell line and that PMA robustly increases ATP7A protein levels in a dose-and time-dependent fashion [18] . To assess ATP7A expression in freshly isolated human macrophages, we performed Western blotting and RT-PCR to examine the protein and mRNA expression, respectively, in human PBMC-derived macrophages and alveolar macrophages. As demonstrated in Fig. 2 , protein and mRNA expression of ATP7A were detected in both types of human macrophages.
Subcellular Location of ATP7A in Human Macrophages.
To assess the subcellular distribution of ATP7A in macrophages, immunofluorescence and confocal microscopy were performed. We detected a partial co-localization between ATP7A and the trans-Golgi apparatus (labeled by TGN46) in human PBMC-derived macrophages (Figs. 3e and i) around one side of perinuclear space (Fig. 3f) .
Increased Intracellular Copper Level in ATP7A-Deficient Macrophages. Our previous study showed that the intracellular copper level was significantly higher in human THP-1 cells treated with ATP7A siRNA as compared to control siRNA [18] . Moreover, PMA treatment led to increased ATP7A expression and decreased cellular copper levels, which was blocked by downregulation of ATP7A [18] . To further confirm the role of endogenous ATP7A in regulating copper in freshly isolated primary macrophages, we assayed cellular copper levels in peritoneal macrophages isolated from ATP7A-deficient mice versus control mice. Consistent with our findings in ATP7A siRNA treated THP-1 cells, we observed that murine peritoneal macrophages lacking ATP7A have higher cellular copper levels as compared with wild-type macrophages (Fig. 4) . These findings confirm that endogenous ATP7A regulates copper levels in macrophages.
ATP7A Downregulation Modulates THP-1 Cell Responses to a Dermal Wound. In our previous study, we validated siRNA-mediated downregulation of ATP7A expression in THP-1 cells [18] . Thus, we used this approach to investigate whether endogenous ATP7A regulates macrophage responses to a dermal wound. First, in order to verify that THP-1 cells can accumulate in wounded tissue, the cells were labeled with a fluorescence marker, calcein AM. Using a confocal microscopy, we readily detected the fluorescence signal in the tissue (Fig. 5a) , indicating the accumulation of THP-1 cells in the wound. The signal was specific for THP-1 cells because no fluorescence signal was detected in a wound loaded with unlabeled THP-1 cells (Fig. 5b) . Moreover, compared with identically labeled cells adherent to glass slides, THP-1 cells present in wounded tissues were smaller in size and inhomogeneous in appearance (compare Figs. 5a with c), consistent with phenotypic alterations during migration and tissue adherence.
Next, we examined the impact of ATP7A downregulation on THP-1 cell accumulation in dermal wounds. We assayed the expression of macrophage markers (MAC2 and CD68) to quantify THP-1 cell accumulation because downregulation of ATP7A only does not change the expression of these markers (data not shown). Figure 5d shows that the expression of MAC2 was reduced in wounds loaded with ATP7A-downregulated THP-1 cells at 4 days. Additional studies to detect the expression of CD68 (another macrophage marker) led to the same tendency (n=4; p<0.05). Note that the PCR primers used here are specific for human and do not amplify mouse sequences. These results indicate that endogenous ATP7A mediates macrophage responses to dermal wounds in vivo. of copper accumulation in tissues during wound healing. We found that 11 days are required for complete healing of the wounds in this model (Fig. 6, top panel) . In the early stages of wound healing, the copper concentrations remained unchanged. And the copper concentration showed a tendency to increase at day 11 postwounding (Fig. 6, bottom panel) , accompanied by regenerated epidermis (data not shown).
DISCUSSION
Trace metals are thought be to inhomogeneously distributed in biological cells and tissues. Thus, it is necessary to apply novel bioimaging techniques with high spatial resolution to investigate the physiology of biometals [19, 20] . SXRF is a new generation of X-ray technique to map the metal topography in biological samples [21] . The copper topography in nucleus and cytoplasm can be readily observed by this technique in ). Cell lysates were prepared, and the supernatants were subjected to copper measurement as described in the "MATERIALS AND METHODS" section. The sample values were normalized to the total protein content and are presented as relative copper concentration. Values are the mean ± SE for three independent experiments, and each experiment was repeated five times; p<0.05 versus ATP7A +/y cells. AM were observed by a Zeiss LSM510 META confocal microscope, as described in the "MATERIALS AND METHODS" section. c THP-1 cells labeled with calcein AM on a glass slide were observed by a confocal microscope under the same conditions. d After incubation with either 5 nM of ATP7A-specific or control siRNA oligonucleotides for 24 h, human THP-1 cells were loaded into wounds as described in the "MATERIALS AND METHODS" section. After that, the wound tissues were homogenized, and total RNA was isolated to detect expression of human MAC-2 as an index of THP-1 gene expression; *p<0.01 versus control, n=3 wounds per group.
THP-1 cells after copper treatment (Fig. 1) , and the copper concentration in nucleus is higher than cytoplasm, which is also observed in several other studies using the cultured cells [21] . However, these in vitro findings are inconsistent with a recent in vivo study by Ralle et al. [22] . In the latter study using in situ hepatocytes, although significant amount of copper was detected in the nucleus (20-69 μM), copper was highest in the cytoplasm [22] . The reasons for this discrepancy are unknown; note that extracellular environments and intracellular signaling pathways between cultured cells and intact tissues may be distinct. In addition, previous study indicated that estimated free copper is extraordinary limited and is less than 10 −18 M in a cell [3] . Therefore, intracellular copper content is tightly controlled in cells by a group of copper chaperones and transporters [3] , such as ATP7A.
Consistent with the previous study, our data indicate that ATP7A mainly localizes to trans-Golgi apparatus and egresses copper in macrophages studied herein. Recently, Collins et al. [23] reported that ATP7A is strongly expressed in the nucleus of IEC-6 and Caco-2 cells and in rat intestine. Although we did not replay this finding in our cells, it is intriguing to examine whether ATP7A can translocate into nucleus under certain stimulations in macrophages in the future study. In addition to trans-Golgi apparatus and nucleus, other reported subcellular locations of ATP7A include lipid rafts [24] and phagosome [11] .
We chose nude mice to study the function of ATP7A in macrophages in vivo because these T-celldeficient mice are widely used to investigate the function of transplanted human cells, particularly genetically modified cells, in dermal wounds [25] and cancer. Moreover, macrophage distribution and density are not significantly altered between nude and control mice after a wound [26] , indicating that nude mice can replicate the physiological behavior of macrophages. Because macrophage accumulation occurs in the early stages of wound healing, we chose day 4 after wounding to load THP-1 cells into the wound.
Copper has been postulated as a dynamic signal molecule [1] . In response to hypoxia [12] or PMA induction [14] , intracellular copper contents and the corresponding expression of copper transporters start to change, although the biological consequence remains unknown. Moreover, our current data hints that as compared with control macrophages, ATP7A-deficient macrophages accumulate to a lesser extent in response to dermal wounds. Note that copper has been used to treat dermal wounds and copper deficiency has been proposed to contribute to the delayed healing of human chronic wounds [27, 28] . In order to better understand the mechanism related to the role of copper in dermal wounds, we sought to determine whether copper concentrations change during the process of wound healing. However, we did not detect a significant change in the copper concentration of wound tissues in the earlier stage of dermal wound healing.
Macrophage accumulation includes adhesion and migration. Chavakis et al. observed that treatment of Cu 2+ in a concentration range between 5 and 100 μmol/L has no effect on adhesion of U937 cells [29] . We have not yet examined the more detailed signaling pathways related to the reduction of macrophage accumulation within the dermal wound in response to ATP7A downregulation. However, recent studies hint that the following machineries could involve into. First, Rac proteins induce lamellipodia extension that push the plasma membrane outward through actin polymerization and play an important role in cell migration [30] . Ashino et al. [24] recently reported that downregulation of ATP7A expression using siRNA significantly decreases vascular smooth muscle cell (VSMC) migration in response to platelet-derived growth factor (PDGF) and wound scratch [24] . To gain the mechanistic insight, the authors discovered that downregulation of ATP7A reduces PDGF-induced Rac1 translocation and lamellipodia formation [24] . Macrophages, such as THP-1 cells, form long pseudopodia and lamellipodia once they attach to the endothelium [31] or are under the stimulation of LPS [32] and cytokine [33] . Therefore, the finding by Ashino et al. in VSMC could be replayed in macrophages, downregulation. Second, vascular endothelial growth factor (VEGF) receptor 1, an important member of the VEGF receptor family, binds VEGF and mediates macrophage recruitment and cancer metastasis [34] [35] [36] . Zhou et al. reported that a copper-induced cardiovascular event is associated with VEGF receptor 1 signaling pathway in vivo [37] . Moreover, the studies by other laboratory and ours showed that PMA markedly induces VEGF receptor 1 expression in THP-1 cells [14, [38] [39] [40] , which is reversed by ATP7A downregulation [14] . Therefore, downregulation of ATP7A in THP-1 cells might reduce their migration in response to dermal wounds via the regulation of the VEGF receptor 1 expression. Third, cytosolic phospholipase A 2α (cPLA 2α ) is a critical regulatory enzyme in integrin adhesion, and downregulation of cPLA 2α decreases cell migration [41, 42] . Jak-2/STAT-3/cPLA 2α pathway is involved into PDGFinduced VSMC motility [43] . Moreover, ATP7A downregulation leads to reduced cPLA 2α expression and activity in THP-1 cells [15] . Therefore, cPLA 2α could lead another candidate pathway to regulate ATP7A dependent macrophage migration. Fourth, SOD3, a key regulator of reactive oxygen species (ROS) in the extracellular space, and ROS have been proposed as signaling molecules and are critical for neovascularization in the ischemic heart [44] , hindlimb [45] , and wound healing [46] in vivo. Recruitment of inflammatory cells into ischemic tissues is significantly reduced in SOD3 knockout mice as compared with controls [47] . In the previous reports, we also have identified that vascular ATP7A is required for the full activation of SOD3, because ATP7A deficiency leads to impaired activity of SOD3 [7, 8] . Overall, we posit that a dynamic network related to the regulation of ROS, integrin, and actin polymerization may contribute to the reduced macrophage accumulation in response to ATP7A downregulation. In summary, we report that copper is distributed to the nucleus and cytoplasm in human THP-1 cells. ATP7A is primarily distributed to the trans-Golgi apparatus in macrophages. Peritoneal macrophages harvested from ATP7A-deficient mice exhibited increased cellular copper levels, indicating a critical role for endogenous ATP7A in regulating copper homeostasis in these cells. Finally, downregulation of ATP7A in THP-1 cells led to reduced THP-1 cell accumulation in a dermal wound model, indicating that ATP7A mediates responses of macrophages to wounds. Together, these findings provide new insight into copper regulation in macrophages and hint that ATP7A may modulate aspects of macrophage function pertinent to wound healing, inflammation, and perhaps, atherosclerosis.
ACKNOWLEDGMENTS
This work was supported by a National Scientist Development Grant (0835268N) from the American Heart Association and grants HL-076684 and HL-62984 from the National Institute of Health. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. We thank Birgit Ehmer and Chet Closson for assisting with the immunofluorescence microscopy and confocal microscopy, Dr. Oyebode Olakanmi for developing the protocol to isolate human PBMC-derived macrophages, and Dr. Dennis McGraw for providing human alveolar macrophages.
